Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.
about
Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.Association between poor therapy adherence to inhaled corticosteroids and tiotropium and morbidity and mortality in patients with COPD.Pneumonia in Patients with Chronic Obstructive Pulmonary Disease.Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
P2860
Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Inhaled Corticosteroid use and ...... erbations in the UPLIFT Study.
@ast
Inhaled Corticosteroid use and ...... erbations in the UPLIFT Study.
@en
type
label
Inhaled Corticosteroid use and ...... erbations in the UPLIFT Study.
@ast
Inhaled Corticosteroid use and ...... erbations in the UPLIFT Study.
@en
prefLabel
Inhaled Corticosteroid use and ...... erbations in the UPLIFT Study.
@ast
Inhaled Corticosteroid use and ...... erbations in the UPLIFT Study.
@en
P2093
P2860
P1433
P1476
Inhaled Corticosteroid use and ...... erbations in the UPLIFT Study.
@en
P2093
Alan Rigby
Alyn H Morice
Jaymin B Morjaria
P2860
P2888
P304
P356
10.1007/S00408-017-9990-8
P577
2017-03-03T00:00:00Z
P6179
1084021639